1998
DOI: 10.1016/s0161-6420(98)91421-x
|View full text |Cite
|
Sign up to set email alerts
|

Combination of systemic acetazolamide and topical dorzolamide in reducing intraocular pressure and aqueous humor formation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
13
0

Year Published

2006
2006
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 41 publications
(13 citation statements)
references
References 17 publications
0
13
0
Order By: Relevance
“…[6][7][8][9][10][11][12][13] The studies have been conducted in various circumstances, including after cataract extraction and lens implantation, after YAG laser capsulotomy, normal adult cases, and primary open angle glaucoma. The results have been variable, with some studies suggesting topical CAI to be superior, oral CAI to be superior, or equally effective in lowering the IOP.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…[6][7][8][9][10][11][12][13] The studies have been conducted in various circumstances, including after cataract extraction and lens implantation, after YAG laser capsulotomy, normal adult cases, and primary open angle glaucoma. The results have been variable, with some studies suggesting topical CAI to be superior, oral CAI to be superior, or equally effective in lowering the IOP.…”
Section: Discussionmentioning
confidence: 99%
“…8 All glaucoma medications were stopped at least 1 week before enrollment. In the first arm of the study topical dorzolamide 2% for 1 week was followed by one tablet of oral acetazolamide at 250 mg.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Three applications per day provide better overall ocular hypotensive effect (Lippa et al, 1992). The combination of topical dorzolamide and oral acetazolamide failed to demonstrate an additive effect (Rosenberg et al, 1998); therefore, combination therapy is not recommended as it may increase the risk of unwanted systemic side effects. Topical dorzolamide also provided further IOP reduction as adjunctive therapy with topical timolol, especially in gel solution (Adamsons et al, 1998a).…”
Section: Carbonic Anhydrase Inhibitorsmentioning
confidence: 99%